Tokunaga et al. [12] found that THBS2 expressed in patients with colon cancer exhibited a significant lower risk of hepatic metastases and tumour vascularity compared with the patients whose tumours were THBS2 deficiency. This evidence concerns the gene THBS2 and neoplasm.